Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors
申请人:Peters Dan
公开号:US20070287728A1
公开(公告)日:2007-12-13
This invention relates to novel naphthyl substituted azabicyclo derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Naphthyl substituted azabicyclo derivatives and their use as monomine neurotransmitter re-uptake inhibitors
申请人:Neurosearch A/S
公开号:US08022081B2
公开(公告)日:2011-09-20
This invention relates to novel naphthyl substituted azabicyclo derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
NOVEL NAPHTHYL SUBSTITUTED AZABICYCLO DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
申请人:NEUROSEARCH A/S
公开号:EP1831213A1
公开(公告)日:2007-09-12
US8022081B2
申请人:——
公开号:US8022081B2
公开(公告)日:2011-09-20
[EN] NOVEL NAPHTHYL SUBSTITUTED AZABICYCLO DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS<br/>[FR] NOUVEAUX DERIVES D'AZABICYCLO SUBSTITUES PAR NAPHTYLE ET LEUR UTILISATION COMME INHIBITEURS DE RECAPTAGE DES NEURO-TRANSMETTEURS DE LA MONOAMINE
申请人:NEUROSEARCH AS
公开号:WO2006067090A1
公开(公告)日:2006-06-29
[EN] 304-204-WO 19 ABSTRACT NOVEL NAPHTHYL SUBSTITUTED AZABICYCLO DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS This invention relates to novel naphthyl substituted azabicyclo derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. [FR] Cette invention concerne des dérivés d'azabicyclo substitués par naphtyle, utiles comme inhibiteurs de recaptage des neuro-transmetteurs de la monoamine. Dans d'autres aspects, l'invention concerne l'utilisation de ces composés dans une méthode de traitement, et des compositions pharmaceutiques comprenant les composés de l'invention.